Unlike SKOV3, TOV112D, and HEY ovarian cancer cells, T80 and T29 normal ovarian epithelial cells did not exhibit decreased levels of p-CDK1, p-CDK2, or p-Rb when treated with URMC099 (Fig. 5B). This evidence concerns the gene CDK2 and ovarian cancer.